Follow
Tebyan O. Mirgany
Tebyan O. Mirgany
College of Pharmacy, King Saud University
Verified email at ksu.edu.sa
Title
Cited by
Cited by
Year
Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity
TO Mirgany, AN Abdalla, M Arifuzzaman, AFM Motiur Rahman, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 2055-2067, 2021
122021
Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo [2, 3-d] pyrimidine as multi-kinase inhibitors
AS Alanazi, TO Mirgany, NA Alsaif, AA Alsfouk, MM Alanazi
Saudi Pharmaceutical Journal 31 (6), 989-997, 2023
112023
Antiproliferative Activity, Multikinase Inhibition, Apoptosis-Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids
AS Alanazi, TO Mirgany, AA Alsfouk, NA Alsaif, MM Alanazi
Medicina 59 (3), 610, 2023
102023
Synthesis and antimicrobial testing of some quinazolinone compounds
HS Al-Salem, TO Mirgany, F Al-Enizy, AZ Mahmoud, HI El-Subbagh, ...
Lat Am J Pharm 38, 1194-1201, 2019
22019
Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy
TO Mirgany, AFMM Rahman, MM Alanazi
Journal of Molecular Structure 1309, 138177, 2024
12024
Discovery of 1H-benzo[d]imidazole-(halogenated)Benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors
TO Mirgany, HH Asiri, AFMM Rahman, MM Alanazi
Pharmaceuticals 17 (7), 839, 2024
12024
A Renewable Relationship between Epilepsy and Quinazolinones
HS Al-Salem
BP International, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7